The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Background: The aim of the present study is to analyze the efficacy of 68Gallium (Ga)-PSMA-11 PET/CT for detecting and localizing recurrent prostate carcinoma (PC) in patients with different prostate-specific antigen (PSA), PSA velocity (PSAvel) and doubling time (PSAdt). Results: The PR of 68Ga-PSM...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Manuela A., Buchholz, Hans-Georg, Wieler, Helmut J., Höfner, Thomas, Müller-Hübenthal, Jonas, Trampert, Ludwin, Schreckenberger, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817454/
https://www.ncbi.nlm.nih.gov/pubmed/31693724
http://dx.doi.org/10.18632/oncotarget.27239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817454/
https://www.ncbi.nlm.nih.gov/pubmed/31693724
http://dx.doi.org/10.18632/oncotarget.27239

Ejemplares similares